Bnp Paribas Asset Management Holding S.A. Veracyte, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Veracyte, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 936 shares of VCYT stock, worth $25,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
936Holding current value
$25,618% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
301Shares Held
78.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$226 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$213 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$143 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$105 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$104 Million0.85% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.96B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...